Login to Your Account



Colorectal Study, Too

You Gotta Be Kidney? AVEO, Astellas Trying Tivo in Breast

By Randy Osborne
Staff Writer

Tuesday, December 4, 2012
As investors continue to digest news regarding FDA concerns about overall survival trends of renal cell carcinoma patients in a Phase III trial with tivozanib, AVEO Oncology Inc. and Astellas Pharma Inc. have begun a Phase II study with the compound in triple-negative breast cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription